Pharmacokinetic profile of zafirlukast (Q28192516)

Clinical Pharmacokinetics

Europe PubMed Central

title

Pharmacokinetic profile of zafirlukast (English)

0 references

1 reference

1 reference

P N Richard Dekhuijzen

series ordinal

1

0 references

Peter P Koopmans

series ordinal

2

0 references

language of work or name

English

0 references

publication date

2002

0 references

published in

0 references

volume

41

0 references

issue

2

0 references

page(s)

105-14

0 references

cites work

Preclinical exploration of the potential antiinflammatory properties of the peptide leukotriene antagonist ICI 204,219 (Accolate).

1 reference

12 December 2020

An examination of the influence of the epithelium on contractile responses to peptidoleukotrienes and blockade by ICI 204,219 in isolated guinea pig trachea and human intralobar airways

1 reference

12 December 2020

Therapeutic effect of zafirlukast as monotherapy in steroid-naive patients with severe persistent asthma

1 reference

12 December 2020

Zafirlukast improves asthma symptoms and quality of life in patients with moderate reversible airflow obstruction.

1 reference

12 December 2020

Lack of effect of zafirlukast on the pharmacokinetics of azithromycin, clarithromycin, and 14-hydroxyclarithromycin in healthy volunteers

1 reference

12 December 2020

Metabolism and excretion of zafirlukast in dogs, rats, and mice

1 reference

12 December 2020

Effects of 2 weeks of treatment with fluticasone propionate 100 mcg b.d. by comparison with zafirlukast 20 mg b.d. on bronchial hyper-responsiveness in patients with mild to moderate asthma

1 reference

12 December 2020

Churg-Strauss Syndrome in Patients Receiving Montelukast as Treatment for Asthma

1 reference

12 December 2020

Efficacy and duration of action of the antileukotriene zafirlukast on cold air-induced bronchoconstriction

1 reference

12 December 2020

Pulmonary eosinophilia associated with montelukast

1 reference

12 December 2020

Treatment of asthma with drugs modifying the leukotriene pathway.

1 reference

12 December 2020

Effect of the oral leukotriene antagonist, ICI 204,219, on antigen-induced bronchoconstriction in subjects with asthma

1 reference

12 December 2020

Role of leukotrienes in exercise-induced asthma. Inhibitory effect of ICI 204219, a potent leukotriene D4 receptor antagonist

1 reference

12 December 2020

Comparison of zafirlukast (Accolate) absorption after oral and colonic administration in humans

1 reference

12 December 2020

Zafirlukast improves asthma control in patients receiving high-dose inhaled corticosteroids

1 reference

12 December 2020

The role and contribution of leukotrienes in asthma

1 reference

12 December 2020

Effect of leukotriene receptor antagonist therapy on the risk of asthma exacerbations in patients with mild to moderate asthma: an integrated analysis of zafirlukast trials

1 reference

12 December 2020

Leukotriene-receptor antagonists

1 reference

12 December 2020

Combined antagonism of leukotrienes and histamine produces predominant inhibition of allergen-induced early and late phase airway obstruction in asthmatics

1 reference

12 December 2020

Asthma drug linked with Churg-Strauss syndrome

1 reference

12 December 2020

Leukotriene modifiers and Churg-Strauss syndrome: adverse effect or response to corticosteroid withdrawal?

1 reference

12 December 2020

A drug interaction between zafirlukast and theophylline

1 reference

12 December 2020

The leukotriene-antagonist ICI-204,219 inhibits the early airway reaction to cumulative bronchial challenge with allergen in atopic asthmatics

1 reference

12 December 2020

A single dose of zafirlukast reduces LTD4-induced bronchoconstriction in patients on maintenance inhaled corticosteroid therapy

1 reference

12 December 2020

The preclinical pharmacology of ICI 204,219. A peptide leukotriene antagonist

1 reference

12 December 2020

Comparative effects of long-acting beta2-agonists, leukotriene receptor antagonists, and a 5-lipoxygenase inhibitor on exercise-induced asthma

1 reference

12 December 2020

Severe liver injury after treatment with the leukotriene receptor antagonist zafirlukast

1 reference

12 December 2020

Churg-Strauss syndrome associated with zafirlukast

1 reference

12 December 2020

Effectiveness of the leukotriene receptor antagonist zafirlukast for mild-to-moderate asthma. A randomized, double-blind, placebo-controlled trial.

1 reference

12 December 2020

Effect of cysteinyl-leukotriene receptor antagonist ICI 204.219 on allergen-induced bronchoconstriction and airway hyperreactivity in atopic subjects

1 reference

12 December 2020

Leukotriene receptor antagonists and biosynthesis inhibitors: potential breakthrough in asthma therapy.

1 reference

12 December 2020

Steroids and Churg-Strauss syndrome

1 reference

12 December 2020

Effects of 6 weeks of therapy with oral doses of ICI 204,219, a leukotriene D4 receptor antagonist, in subjects with bronchial asthma. ACCOLATE Asthma Trialists Group

1 reference

12 December 2020

Potent leukotriene D4 receptor antagonist ICI 204,219 given by the inhaled route inhibits the early but not the late phase of allergen-induced bronchoconstriction

1 reference

12 December 2020

Leukotrienes as a target in asthma therapy

1 reference

12 December 2020

Zafirlukast for symptomatic mild-to-moderate asthma: a 13-week multicenter study. The Zafirlukast Trialists Group

1 reference

12 December 2020

The effect of zafirlukast on repetitive exercise-induced bronchoconstriction: the possible role of leukotrienes in exercise-induced refractoriness

1 reference

12 December 2020

Churg-Strauss syndrome after zafirlukast in two patients not receiving systemic steroid treatment

1 reference

12 December 2020

Zafirlukast. A review of its pharmacology and therapeutic potential in the management of asthma

1 reference

12 December 2020

Inhibition of leukotriene D4-induced bronchoconstriction in subjects with asthma: a concentration-effect study of ICI 204,219.

1 reference

12 December 2020

A randomized, double-blind, placebo-controlled trial of the effect of zafirlukast on upper and lower respiratory responses to cat challenge

1 reference

12 December 2020

Effect of zafirlukast (Accolate) on cellular mediators of inflammation: bronchoalveolar lavage fluid findings after segmental antigen challenge.

1 reference

12 December 2020

Determination of zafirlukast, a selective leukotriene antagonist, human plasma by normal-phase high-performance liquid chromatography with fluorescence detection

1 reference

12 December 2020

Pulmonary infiltrates, eosinophilia, and cardiomyopathy following corticosteroid withdrawal in patients with asthma receiving zafirlukast

1 reference

12 December 2020

Comparison of inhaled salmeterol and oral zafirlukast in patients with asthma

1 reference

12 December 2020

Churg-Strauss syndrome associated with zafirlukast.

1 reference

12 December 2020

Two first-line therapies in the treatment of mild asthma: use of peak flow variability as a predictor of effectiveness

1 reference

12 December 2020